THE SENATE

THE TWENTY-NINTH LEGISLATURE

REGULAR SESSION OF 2018

 

COMMITTEE ON COMMERCE, CONSUMER PROTECTION, AND HEALTH

Senator Rosalyn H. Baker, Chair

Senator Jill N. Tokuda, Vice Chair

 

NOTICE OF HEARING

 

 

DATE:

Tuesday, February 13, 2018

TIME:

9:00AM

PLACE:

Conference Room 229

State Capitol

415 South Beretania Street

 

A G E N D A

 

SB 2651

      Status & Testimony

RELATING TO MEDICAL CANNABIS DISPENSARIES.

Specifies certain felonies that will preclude employment at a medical cannabis dispensary.

 

CPH, JDC

SB 2132

      Status & Testimony

RELATING TO MANUFACTURED CANNABIS PRODUCTS.

Authorizes the department of health to authorize companies to partner with medical cannabis dispensaries to participate in the manufacture of consumable manufactured cannabis products.  Establishes additional requirements and amends existing requirements regarding manufactured cannabis products.

 

CPH, JDC

SB 2488

      Status & Testimony

RELATING TO MEDICAL CANNABIS.

Establishes the medical cannabis insurance reimbursement working group to address the complexities surrounding the topic of making medical cannabis reimbursable by health insurance.

 

CPH, WAM

SB 3053

      Status & Testimony

RELATING TO EDIBLE CANNABIS PRODUCTS.

Defines edible cannabis products as manufactured cannabis that is intended to be used for human consumption and provides manufacturing requirements for edible cannabis products.  Authorizes licensed medical cannabis dispensaries to manufacture and distribute edible cannabis products.  Establishes requirements for manufacturing, handling, and packaging manufactured cannabis products.  Takes effect on 01/01/2020.

 

CPH, JDC/WAM

SB 2659

      Status & Testimony

RELATING TO MEDICAL CANNABIS PRODUCTS.

Updates transdermal patches to transdermal devices in section 329D-10, HRS, thereby including non-patch devices that deliver through the dermis.  Adds cannabinoid suppositories to the list of cannabis products that may be manufactured and distributed by dispensaries.

 

CPH

SB 2407

      Status & Testimony

RELATING TO MEDICAL CANNABIS.

Allows the use of medical cannabis to treat opioid addiction, substance abuse, and withdrawal symptoms resulting from the treatment of those conditions.

 

CPH

 

 

 

 

Decision Making to follow, if time permits.

 

Click here to submit testimony.

 

Testimony may be submitted up to 24 hours prior to the start of the hearing.

 

FOR AMENDED NOTICES:  Measures that have been deleted are stricken through and measures that have been added are underscored.  If a measure is both underscored and stricken through, that measure has been deleted from the agenda.

 

If you require auxiliary aids or services to participate in the public hearing process (i.e. ASL or foreign language interpreter, or wheelchair accessibility), please contact the committee clerk at least 24 hours prior to the hearing so that arrangements can be made.

 

FOR FURTHER INFORMATION, PLEASE CALL THE COMMITTEE CLERK AT (808)586 6070.

 

 

 

 

_____________________________________

Senator Rosalyn H. Baker

Chair